Tandem (Healthcare Technology Systems) key facts
as of Oct 2026- Developer of a prescription wallet designed to provide medicine at an affordable price.
- Tandem (Healthcare Technology Systems) is valued at approximately $950.0M as of Oct 2026 (last reported valuation).
- It has raised $137.4M; the latest was Early Stage VC ($100.0M) in Jan 2026.
- Notable investors include General Catalyst, SOSV, Accel, BoxGroup, Bain Capital Ventures — 14 tracked in total.
- Status: Privately Held (backing).
Tandem (Healthcare Technology Systems)'s last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Tandem (Healthcare Technology Systems): the Monday email on marks, rounds and moves
Tandem (Healthcare Technology Systems) funding rounds
No funding rounds for Tandem (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Tandem (Healthcare Technology Systems)
14+Membership and data by Private Market View
Tandem (Healthcare Technology Systems) valuation
Tandem (Healthcare Technology Systems)'s last reported valuation was $950 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
Tandem (Healthcare Technology Systems) investors
14 investors are on record for Tandem (Healthcare Technology Systems), including General Catalyst, SOSV, Accel and BoxGroup. By type, the record holds 9 venture capital firms.
About Tandem (Healthcare Technology Systems)
Developer of a prescription wallet designed to provide medicine at an affordable price. The company's platform allows doctors to send prescriptions and check insurance coverage, coupons, and prices across pharmacies, enabling patients to get medicines quickly and at a low price and doctors to treat their patients consistently.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 39
- Website
- withtandem.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.